| Year |
Citation |
Score |
| 2019 |
Javaheri A, Bajpai G, Picataggi A, Mani S, Foroughi L, Evie H, Kovacs A, Weinheimer CJ, Hyrc K, Xiao Q, Ballabio A, Lee JM, Matkovich SJ, Razani B, Schilling JD, et al. TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy. Jci Insight. 4. PMID 31672943 DOI: 10.1172/Jci.Insight.127312 |
0.305 |
|
| 2019 |
Murphy JT, Liu H, Ma X, Shaver A, Egan BM, Oh C, Boyko A, Mazer T, Ang S, Khopkar R, Javaheri A, Kumar S, Jiang X, Ory D, Mani K, et al. Simple nutrients bypass the requirement for HLH-30 in coupling lysosomal nutrient sensing to survival. Plos Biology. 17: e3000245. PMID 31086360 DOI: 10.1371/Journal.Pbio.3000245 |
0.307 |
|
| 2019 |
Ma X, Mani K, Liu H, Kovacs A, Murphy JT, Foroughi L, French BA, Weinheimer CJ, Kraja A, Benjamin IJ, Hill JA, Javaheri A, Diwan A. Transcription Factor EB Activation Rescues Advanced αB-Crystallin Mutation-Induced Cardiomyopathy by Normalizing Desmin Localization. Journal of the American Heart Association. 8: e010866. PMID 30773991 DOI: 10.1161/Jaha.118.010866 |
0.331 |
|
| 2014 |
Javaheri A, Rader DJ, Javaheri S. Statin therapy in heart failure: is it time for a second look? Hypertension. 63: 909-10. PMID 24516102 DOI: 10.1161/Hypertensionaha.113.02703 |
0.31 |
|
| 2007 |
McSherry TD, Kitazono AA, Javaheri A, Kron SJ, Mueller PR. Non-catalytic function for ATR in the checkpoint response. Cell Cycle (Georgetown, Tex.). 6: 2019-30. PMID 17721080 DOI: 10.4161/Cc.6.16.4553 |
0.569 |
|
| 2006 |
Wysocki R, Javaheri A, Kristjansdottir K, Sha F, Kron SJ. CDK Pho85 targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after DNA damage. Nature Structural & Molecular Biology. 13: 908-14. PMID 16964260 DOI: 10.1038/Nsmb1139 |
0.574 |
|
| 2006 |
Javaheri A, Wysocki R, Jobin-Robitaille O, Altaf M, Côté J, Kron SJ. Yeast G1 DNA damage checkpoint regulation by H2A phosphorylation is independent of chromatin remodeling. Proceedings of the National Academy of Sciences of the United States of America. 103: 13771-6. PMID 16940359 DOI: 10.1073/Pnas.0511192103 |
0.586 |
|
| 2006 |
Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR, Kron SJ. gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. Current Cancer Drug Targets. 6: 197-205. PMID 16712457 DOI: 10.2174/156800906776842957 |
0.587 |
|
| 2005 |
Wysocki R, Javaheri A, Allard S, Sha F, Côté J, Kron SJ. Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9. Molecular and Cellular Biology. 25: 8430-43. PMID 16166626 DOI: 10.1128/Mcb.25.19.8430-8443.2005 |
0.584 |
|
| 2005 |
Kao J, Wysocki R, Javaheri A, Milano M, Kron S, Weichselbaum R. Measuring γ-H2AX Induction after Ionizing Radiation (IR) and Drug Therapy using a Streamlined Flow Cytometry Assay International Journal of Radiation Oncology*Biology*Physics. 63: S476. DOI: 10.1016/J.Ijrobp.2005.07.810 |
0.49 |
|
| 2004 |
Downs JA, Allard S, Jobin-Robitaille O, Javaheri A, Auger A, Bouchard N, Kron SJ, Jackson SP, Côté J. Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Molecular Cell. 16: 979-90. PMID 15610740 DOI: 10.1016/J.Molcel.2004.12.003 |
0.569 |
|
| Show low-probability matches. |